文献速递外周动脉疾病

膝下原位大隐静脉旁路术后常规超声监测在严重肢体缺血中的作用

The Role of Routine Ultrasound Surveillance after In Situ Infrainguinal Peripheral Vein Bypass for Critical Limb-Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2020-02-05

本研究回顾性分析2011至2015年间363例因严重肢体缺血行择期膝下原位大隐静脉旁路术的患者,评估术后系统超声监测的效果。结果显示23%患者接受移植物保全性再干预,但仅20例次仅由常规超声触发,需筛查60例患者才能发现1例无症状需干预的移植物狭窄。作者建议制定个体化监测方案以区分高危和低危患者。

要点

  • 常规超声监测发现的需干预无症状移植物狭窄比例很低,需筛查60例患者才发现1例。
  • 术后3年辅助一期通畅率为73.6%,生存率为47.7%。
  • 多数移植物病变通过临床表现发现,而非仅靠常规超声。

核心结论

  • 每4例患者中1例接受移植物保全性再干预,但极少数由常规超声驱动,多数病变经临床发现。
  • 建议开发个体化监测方案区分高危和低危膝下旁路患者以提高成本效益。

研究设计与样本

  • 单中心回顾性分析前瞻性登记数据,纳入2011至2015年因严重肢体缺血行择期膝下原位大隐静脉旁路术的连续患者363例。
  • 术后监测包括临床检查、踝肱指数和超声,于6周、3个月和12个月进行,超声由受训护士操作。

主要发现

  • 310例患者至少完成一次随访,共进行1199次超声检查。
  • 84例(23%)患者接受125次移植物保全性再干预,其中20次仅由常规超声触发(无缺血症状且踝肱指数下降≤15%)。
  • 术后1、2、3年辅助一期通畅率分别为79.4%(95%CI: 74.4, 83.5)、76.3%(95%CI: 70.7, 81.0)和73.6%(95%CI: 66.9, 79.2)。
  • 术后1、2、3年生存率分别为82.6%(95%CI: 78.1, 86.3)、64.2%(95%CI: 57.8, 69.9)和47.7%(95%CI: 40.6, 54.4)。

关键数值与推荐

  • 发现1例无症状需再干预的移植物狭窄需筛查60例患者。
  • 移植物保全性再干预指征包括缺血症状和/或踝肱指数显著下降(>15%)。

临床怎么用

  • 膝下原位大隐静脉旁路术后常规超声监测可能成本效益较低,应考虑个体化方案。
  • 临床评估和踝肱指数监测在发现移植物病变中起重要作用,不应被常规超声替代。

局限性

  • 单中心回顾性研究,可能存在选择偏倚。
  • 超声由护士操作,结果可能受操作者经验影响。
  • 未报告无随访患者的详细情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate systematic duplex ultrasound (DUS) surveillance of patients treated with in situ great saphenous vein bypass (ISSVB) due to critical limb-threatening ischemia (CLTI) we performed a retrospective analysis of prospectively entered registry data. METHODS: Single-center study including consecutive patients undergoing elective ISSVB surgery due to CLTI between 2011 and 2015. Postoperative graft surveillance program included clinical examination, ankle-brachial indices (ABIs), and DUS at 6 weeks and 3 and 12 months. All DUS scans were performed by trained nurse sonographers. Patient data were extracted from the Danish Vascular Registry, electronic medical records and Picture Archiving and Communication System (PACS). Primary outcomes were reintervention rate, patency, and survival. RESULTS: In total, 363 consecutive and treatment-naive CLTI patients were revascularized with ISSVB and included in the study. Of those, 310 patients had minimum one follow-up visit and in total 1,199 DUS examinations. During the study period, 84 (23%) patients received 125 graft preserving reinterventions of which 20 were indicated solely on routine DUS without concurrent ischemic symptoms and/or significant (>15%) decrease in ABI. Hence, to find one asymptomatic graft stenosis requiring reintervention, we needed to scan 60 patients. After 1, 2, and 3 years, assisted primary patency was (Kaplan-Meier estimate) 79.4% (95% CI: 74.4, 83.5), 76.3% (95% CI: 70.7, 81.0), and 73.6% (95% CI: 66.9, 79.2), respectively. Survival rates were 82.6% (95% CI: 78.1, 86.3), 64.2% (95% CI: 57.8, 69.9) and 47.7% (95% CI: 40.6, 54.4) at 1, 2, and 3 years, respectively. CONCLUSIONS: In this study, one in four patients received a graft preserving intervention, but very few were driven by routine DUS and most graft lesions were detected on clinical findings. These findings suggest that development of a more individualized surveillance program differentiating between high- and low-risk infrainguinal bypass patients may increase cost-effectiveness.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fisker L, Eiberg J, Sillesen H, et al. The Role of Routine Ultrasound Surveillance after In Situ Infrainguinal Peripheral Vein Bypass for Critical Limb-Threatening Ischemia. Ann Vasc Surg. 2020. PMID: 32035262. doi:10.1016/j.avsg.2020.01.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。